Cargando…
Measurement, modeling and QALYs
Over the past 30 years, a mainstay of health technology assessment has been the creation of modeled incremental cost-per-quality adjusted life year (QALY) claims. These are intended to inform resource allocation decisions. Unfortunately, the reliance on the construction of QALYs from generic utility...
Autores principales: | Langley, Paul C., McKenna, Stephen P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533730/ https://www.ncbi.nlm.nih.gov/pubmed/33093950 http://dx.doi.org/10.12688/f1000research.25039.1 |
Ejemplares similares
-
INNOVATIONS in pharmacy10(th) Anniversary Celebration: Special ‘Call for Papers’ in the Formulary Evaluations Section of the Journal Post QALY: Scientific Approaches to Real World Formulary Decision Making
por: Langley, Paul C, et al.
Publicado: (2020) -
Abandoning Eugenics and the QALY
por: Langley, Paul C
Publicado: (2021) -
The Great I-QALY Disaster
por: Langley, Paul C.
Publicado: (2020) -
ICER, ISPOR AND QALYs: Tales of Imaginary Worlds
por: Langley, Paul C
Publicado: (2019) -
The PROMIS of QALYs
por: Hanmer, Janel, et al.
Publicado: (2015)